Published in Int J Radiat Oncol Biol Phys on September 12, 2006
Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol (2011) 1.35
Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18
Role of radiotherapy in melanoma management. Radiol Oncol (2010) 1.17
The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys (2011) 1.04
Adjuvant therapy for melanoma. Cancer J (2012) 1.01
Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Neuro Oncol (2015) 0.92
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther (2011) 0.88
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition). Ann Transl Med (2015) 0.76
Isolated malignant melanoma metastasis to the pancreas. Plast Reconstr Surg Glob Open (2013) 0.75
Chemotherapy Resistance Mechanisms in Advanced Skin Cancer. Oncol Rev (2017) 0.75
A retrospective analysis of the role of adjuvant radiotherapy in the treatment of cutaneous melanoma. Cancer Biol Ther (2016) 0.75
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy. Onco Targets Ther (2016) 0.75
Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma. Ochsner J (2010) 0.75
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA (2003) 3.93
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol (2006) 2.68
Proton therapy for prostate cancer. Oncology (Williston Park) (2011) 2.11
Radiotherapy for pleomorphic adenoma. Am J Otolaryngol (2012) 2.04
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.97
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Management of T1-T2 glottic carcinomas. Cancer (2004) 1.87
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer (2002) 1.76
Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys (2007) 1.62
External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys (2002) 1.60
Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck (2004) 1.59
Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol (2010) 1.58
Head and neck mucosal melanoma. Am J Clin Oncol (2005) 1.53
Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.52
Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol (2002) 1.51
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck (2002) 1.45
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.44
Linear accelerator surgery for meningiomas. J Neurosurg (2005) 1.43
Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol (2014) 1.42
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol (2006) 1.42
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.35
Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys (2006) 1.34
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope (2009) 1.33
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.32
Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck (2004) 1.30
Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol (2006) 1.27
Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer (2005) 1.26
Head and neck paragangliomas. Head Neck (2010) 1.24
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer (2006) 1.22
External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol (2005) 1.21
Skin carcinoma of the head and neck with perineural invasion. Am J Otolaryngol (2011) 1.20
Mucosal melanoma of the head and neck. Am J Clin Oncol (2008) 1.19
The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys (2006) 1.18
Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol (2005) 1.17
Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med (2002) 1.17
Skin cancer of the head and neck with perineural invasion. Am J Clin Oncol (2007) 1.17
Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol (2005) 1.15
Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck (2002) 1.13
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol (2013) 1.13
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck (2003) 1.13
Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck (2012) 1.13
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope (2009) 1.12
Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope (2009) 1.11
Ewing tumors of the head and neck. Am J Clin Oncol (2010) 1.11
Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol (2010) 1.11
Radiation therapy for angiosarcoma. Head Neck (2003) 1.11
Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys (2007) 1.11
Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope (2008) 1.09
Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol (2006) 1.07
Mandibular osteoradionecrosis. J Clin Oncol (2004) 1.07
Aggressive fibromatosis. Am J Clin Oncol (2005) 1.06
Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer (2004) 1.06
Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys (2005) 1.06
Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.05
Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck (2003) 1.05
Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.04
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer (2012) 1.04
Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol (2012) 1.04
Management of sinonasal undifferentiated carcinoma. Head Neck (2008) 1.04